JP Morgan Upgrades Alcon to Overweight

Analyst Michael Weinstein says despite the Retaane setback, he sees solid growth potential for the eye-care company

JP Morgan upgraded eye-care company Alcon (ACL ) to overweight, but cut the estimates.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.